Upgrade to SI Premium - Free Trial

Concerns Around CVS Health (CVS) Accelerated PBM Losses Likely Overblown - Cantor Fitzgerald

March 27, 2019 11:08 AM
Cantor Fitzgerald analyst Steven Halper reiterated an Overweight rating and $80.00 price target on CVS Health (NYSE: CVS) saying concerns ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles